Back To Top
HERALD INTERVIEW
[Herald Interview] Avellino Labs balances focus between COVID tests, gene therapy ahead of IPO
[Herald Interview] Avellino Labs balances focus between COVID tests, gene therapy ahead of IPO
MarketsApr 18, 2021
After achieving a strong earnings growth last year, biotech firm Avellino Labs is seeking to refocus on its pipeline with gene editing technology ahead of its planned market debut on South Korea’s se...